• Paklitaxfil Inj 30mg 1Vial
1 1

Atco Laboratories (Pvt) Ltd

Paklitaxfil Inj 30mg 1Vial

Paklitaxfil Inj 30mg 1Vial

Rs.5,550.00 PKR
Rs.6,000.00 PKR Rs.5,550.00 PKR
Sale Sold out
Shipping calculated at checkout.

[Tab 1]
[Tab Title]Product Description[End Tab Title]
[Tab Body]
Generic Category: Anti-Cancer
Ingredients: Paclitaxel
Strength: 30mg
Pack Size: 1 Vial
[end-tab-body]
[end-tab-1]

[Tab 2]
[Tab Title]Product Highlights[End Tab Title]
[Tab Body]
Manufacturer: Atco Laboratories
Country of Origin: Pakistan
Pack Form: Pack of 1 Vial of Injection
Product Form: Injection
Product Type: Medicine
[end-tab-body]
[end-tab-2]

[Tab 3]
[Tab Title]Usage and Safety Information[End Tab Title]
[Tab Body]
Key Highlights: Anticancer chemotherapy (paclitaxel, taxane group) used for solid tumors; high-alert hospital-only medicine requiring strict oncology monitoring and infusion precautions
Storage: Store at 20–25°C, protect from light, do not freeze
Habit Forming: No
Sedation: No
Route of Administration: Intravenous (IV) infusion only under oncology supervision
[end-tab-body]
[end-tab-3]

Side Effects

  • Myelosuppression (low WBC, neutropenia, anemia, thrombocytopenia), alopecia, nausea and vomiting, peripheral neuropathy (tingling/numbness), myalgia/arthralgia, hypersensitivity reactions during infusion (flushing, rash, bronchospasm), fatigue and weakness, elevated liver enzymes, and rarely bradycardia or hypotension during infusion.

Diagnostic Categories

  • breast cancer (adjuvant and metastatic), ovarian cancer, non-small cell lung cancer, Kaposi’s sarcoma, and other solid tumors, either as monotherapy or in combination chemotherapy regimens for advanced malignancies.

Generic Classification

  • Generic Category: medicinal

Generic Group Attributes

  • Class: Anti-Mitotic
  • Sub Group: Taxane Derivative
  • Subcategory: Anti-Cancer
View full details